Explore Latest Clinical Trials News With Medical Device Insights

10-Year Data from the Medtronic ENGAGE OUS Registry is the First and Only Prospective, Industry Sponsored Global EVAR Registry to Demonstrate a Decade of Durable Outcomes in Real-World Setting

The ENGAGE OUS registry evaluated more than 1,200 patients. The 10-year data, which included follow-up from approximately 400 of these patients, showed a 94.7 percent freedom from aneurysm-related mortality (ARM) † and 64.1 percent sac regression (or decreased AAA sac diameter) ‡ at 10 years.

April 26, 2023

Nevro Announces Enrollment of First Patient in PDN Sensory Study

The PDN Sensory Study will enroll up to 236 patients at multiple sites across the U.S. Patients will be randomized to conventional medical management or 10 kHz Therapy™ plus conventional medical management, with optional crossover to the other treatment arm at 6 months if those criteria are met.

April 25, 2023

Know Labs Demonstrates Accuracy of Non-Invasive, Bio-RFID Technology with Ground-Breaking Proof-of-Principle Study

“Proof-of-principle studies are critical in demonstrating Bio-RFID accuracy for non-invasive methods of medical diagnostics. This was an essential step toward achieving our goal of delivering the first FDA-cleared, truly non-invasive glucose monitoring device to the market,” said Ron Erickson, CEO and Chairman at Know Labs.

April 21, 2023

Watkins-Conti Completes Stress Urinary Incontinence Yōni.Fit Device Trial

Seventy one (71) participants enrolled in a randomized, controlled, single-blind, multi-center study of the Yōni.Fit device in women with stress urinary incontinence.

April 20, 2023

NICO Corporation’s ENRICH Trial Evaluating Minimally Invasive Parafascicular Surgery (MIPS) for Intracerebral Hemorrhage (ICH) to be Presented at the 2023 AANS Annual Scientific Meeting During Plenary Session I

The ENRICH trial results were accepted as a late-breaker and will be presented on Saturday, April 22 during an oral plenary session beginning at 8:30 a.m. PT (11:30 a.m. ET) by co-lead ENRICH investigator, Gustavo Pradilla, M.D., associate professor of neurosurgery at Emory University School of Medicine and chief of neurosurgery at Grady Memorial Hospital.

April 20, 2023

Ancora Heart and egnite, Inc. Announce Strategic Partnership to Accelerate Clinical Trial Enrollment for Heart Failure Patients

Mark Miles, chief commercial officer of Ancora Heart. “This partnership with egnite and The Christ Health Network will allow us to deploy AI tools such as egnite’s Trial Accelerator and expedite identification of eligible candidates for the CORCINCH-HF trial.”

April 19, 2023

Medical Device News Magazine

A Publication for the Practising Medical Specialist, Industry Executive & Investor

CLINICAL TRIALS, STUDIES, REGISTRIES, DATA